Editorial: New therapeutics for soft tissue sarcomas

Affiliations

Marla Weetall: Pharmacology and Biomarkers, PTC Therapeutics (United States), South Plainfield, NJ, United States
Mark Rance: Pharmacology and Biomarkers, PTC Therapeutics (United States), South Plainfield, NJ, United States
Matthew Ingham: Clinical Development, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States
Brian A. Van Tine: Division of Medical Oncology, Washington University in St. Louis, St. Louis, MO, United States
Brian A. Van Tine: Siteman Cancer Center, St. Louis, MO, United States
Brian A. Van Tine: Division of Pediatric Hematology and Oncology, St. Louis Children's Hospital, St. Louis, MO, United States

Abstract

No abstracts available.

ISSN: 2234-943X (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://www.frontiersin.org/journals/oncology/